Home/SPIMACO/Eng. Fahad Al-Jabr
EF

Eng. Fahad Al-Jabr

Chairman of the Board

SPIMACO

SPIMACO Pipeline

DrugIndicationPhase
Generic Portfolio ExpansionBroad Therapeutic AreasRegistration & Launch
Value-Added & Complex GenericsChronic Diseases (e.g., Diabetes, Hypertension)Development & Registration
Licensed Products from MNC PartnersOncology, Immunology, Specialty CareTechnology Transfer & Localization
Biosimilars DevelopmentImmunology, OncologyExploratory / Early Development